Form 4: Viatris Inc. Executive Le Goff Corinne Reports Acquisition of Restricted Stock Units

Chief Commercial Officer Corinne Le Goff reports the acquisition of 132,493 restricted stock units (RSUs) of Viatris Inc. on March 6, 2025, according to a Form 4 filing.

Summary

• Corinne Le Goff, Chief Commercial Officer of Viatris Inc., filed a Form 4 with the SEC.
• The filing reports the acquisition of 132,493 restricted stock units (RSUs) on March 6, 2025.
• These RSUs represent the right to receive one share of Viatris Inc. common stock each.
• 44,165 of the RSUs will vest on March 6, 2026, 44,164 will vest on March 6, 2027, and 44,164 will vest on March 6, 2028.
• Following the reported transaction, Le Goff directly owns 132,493 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by an executive is generally a good sign, but it's a routine transaction.

Positives

• The acquisition of RSUs by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs (March 6, 2026, 2027, and 2028) suggests a multi-year commitment from the executive.

Industry Context

Executive compensation in the pharmaceutical industry often includes stock-based awards to align management's interests with those of shareholders.

Stakeholder Impact

• The RSU grant aligns the executive's interests with shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates